TGA approves defibrillator without safety evidence before regulators pull device
Australia's medical device regulator approved the CellAED defibrillator in 2021 without clinical evidence it could save lives. The device sparked safety concerns after Britain's regulator yanked it from the market, revealing it delayed shocks by up to 50 seconds during cardiac arrests. Over 23,000 units were distributed to ambulance services before both Victoria and Canberra withdrew.
Take it further — get the full app and never miss a moment of what's happening in Australia.
This publisher's site can't be shown here due to their security settings.
Open full article →No source link available for this article.
Published 18 Jul 2026, 19:00 UTC · Updated 18 Jul 2026, 19:11 UTC
Summary by OZbrief Editorial. Original report: SMH. Editorial policy · Corrections
Trending
- Watchdog directs judge to counselling after 'inappropriate' comments
- Lendlease fund sells Melbourne office tower for half 2022 purchase price
- Democrats accuse Trump administration of delaying bridge opening for billionaire donor
- Greyhound driver under investigation for scrolling videos while driving on highway
- Monty Ioane scores twice in Italy wins over Australia after 2017 arrival
- Vodafone settles legal claim brought by 62 former franchisees